Quantbot Technologies LP Sage Therapeutics, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$27.52 - $37.99 $11,448 - $15,803	-416 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $12,775 - $19,015	416 New	416 $13,000
Q2 2021 Aug 12, 2021	SELL	$54.88 - $79.29 $32,214 - $46,543	-587 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $41,471 - $56,798	587 New	587 $43,000
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $13,831 - $22,998	-533 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $13,937 - $41,168	533 New	533 $15,000
Q4 2019 Feb 10, 2020	SELL	$60.18 - $154.77 $46,398 - $119,327	-771 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $108,163 - $146,459	771 New	771 $108,000
Q4 2018 Feb 13, 2019	SELL	$81.94 - $139.71 $15,650 - $26,684	-191 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $26,379 - $32,286	191 New	191 $26,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.